GlycoMimetics major shareholder Enterprise Associates 13 L. New Purchases 512,500 Shares (GLYC)
GlycoMimetics (NASDAQ:GLYC) major shareholder Enterprise Associates 13 L. New acquired 512,500 shares of the stock on the open market in a transaction dated Wednesday, January 15th. The stock was purchased at an average cost of $8.00 per share, with a total value of $4,100,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Large shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.
GlycoMimetics (NASDAQ:GLYC) traded up 7.24% during mid-day trading on Wednesday, hitting $9.63. 238,584 shares of the company’s stock traded hands. GlycoMimetics has a one year low of $8.40 and a one year high of $9.04. The stock’s 50-day moving average is $8.8 and its 200-day moving average is $8.8. The company’s market cap is $12.0 million.
GlycoMimetics, Inc (NASDAQ:GLYC) is a clinical-stage biotechnology company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.